Clinical Trials Browser

Phase 1/2 × radium Ra 223 dichloride × Plasma cell × Clear all

NCT02928029 2020-02-26

Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma

Phase 1/2 Terminated

7 enrolled 9 charts

Multiple Myeloma

NCT02605356 2016-10-07

Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma

Phase 1/2 Withdrawn

Multiple Myeloma